HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Cellyan Biotechnology Co., Ltd
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026
$0.11+0.00 (+1.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Cellyan Biotechnology's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Liying Wang | 7,150,000 | 65.00% | 13D (active) | Oct 6, 2025 |
| Lap Sun Wong | 6,244,961 | 56.77% | 13G (passive) | Mar 31, 2025 |
| Atlantic Health Century International Group | 617,850 | 5.62% | 13G (passive) | Mar 31, 2025 |
| Pacific Health Century International Group | 617,850 | 5.62% | 13G (passive) | Mar 31, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Chenyu Andy Liang | CEO and Director | – | – | Jun 8, 2026 |
| Zifeng Wang | Chief Strategy Officer | – | – | Jun 9, 2026 |
| Shu Liu | CFO | – | – | Jun 8, 2026 |
| Kam Leung CHAN | Director | – | – | Jun 12, 2026 |
| Lap Sun Wong | Director | 18,468 | 0.11% | Jun 10, 2026 |
| Jingyan Wu | Director | – | – | Jun 8, 2026 |
| Mike Yao Zhou | Director | – | – | Jun 8, 2026 |